Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO11713 | Hypericum scabrum | Species | Hypericaceae | Eukaryota | Uzbekistan |
PMID[15568778] |
||
NPO31026 | Myrica rubra | Species | Myricaceae | Eukaryota | barks |
PMID[23066712] |
||
NPO5755.1 | Bauhinia glauca | Under-species | NA | NA |
PMID[26096681] |
|||
NPO12467 | Cephalanthus occidentalis | Species | Rubiaceae | Eukaryota | TCMID* | |||
NPO12529 | Phedimus aizoon | Species | Crassulaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2 | Others | Unspecified | ID50 | = | 10.05 | nM | 1378087 | |
NPT2 | Others | Unspecified | ID50 | = | 9.69 | nM | 1378087 | |
NPT1579 | Organism | Heliothis virescens | Heliothis virescens | ED50 | = | 0.11 | % | 10.1021/np50025a011 |
NPT2 | Others | Unspecified | Activity | = | 37.7 | 8882428 | ||
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | > | 20000 | ug/ml | 15568778 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 11200 | ug/ml | 15568778 |
NPT81 | Cell Line | A549 | Homo sapiens | Inhibition | = | 13 | % | 15568778 |
NPT2 | Others | Unspecified | ID50 | > | 500 | ug/ml | 2607357 | |
NPT2 | Others | Unspecified | Activity | = | 0.89 | MU | 19944611 | |
NPT2 | Others | Unspecified | Inhibition | = | 20 | % | 22578462 | |
NPT2 | Others | Unspecified | Activity | = | 13198 | umolequiv/g | 23066712 | |
NPT2 | Others | Unspecified | IC50 | = | 127.5 | ug/ml | 23066712 | |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 20.85 | % | 23062825 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | -2.1 | % | 23062825 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC135599 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC277174 |
1.0 | High Similarity | NPC73855 |
1.0 | High Similarity | NPC113968 |
1.0 | High Similarity | NPC328940 |
0.9936 | High Similarity | NPC127546 |
0.9936 | High Similarity | NPC52550 |
0.9936 | High Similarity | NPC19388 |
0.9936 | High Similarity | NPC325555 |
0.9936 | High Similarity | NPC226304 |
0.9936 | High Similarity | NPC223424 |
0.9936 | High Similarity | NPC265530 |
0.9936 | High Similarity | NPC84362 |
0.9936 | High Similarity | NPC173637 |
0.9936 | High Similarity | NPC240431 |
0.9936 | High Similarity | NPC317489 |
0.9936 | High Similarity | NPC55786 |
0.9873 | High Similarity | NPC145038 |
0.9873 | High Similarity | NPC88789 |
0.9873 | High Similarity | NPC219904 |
0.9873 | High Similarity | NPC118284 |
0.9873 | High Similarity | NPC120099 |
0.9873 | High Similarity | NPC56077 |
0.9873 | High Similarity | NPC253662 |
0.9873 | High Similarity | NPC203050 |
0.9873 | High Similarity | NPC223747 |
0.9873 | High Similarity | NPC276222 |
0.9873 | High Similarity | NPC308404 |
0.9873 | High Similarity | NPC274618 |
0.9873 | High Similarity | NPC179950 |
0.9873 | High Similarity | NPC281131 |
0.9873 | High Similarity | NPC225434 |
0.9811 | High Similarity | NPC95866 |
0.9811 | High Similarity | NPC244776 |
0.9811 | High Similarity | NPC206123 |
0.9811 | High Similarity | NPC116864 |
0.9809 | High Similarity | NPC277205 |
0.9808 | High Similarity | NPC473043 |
0.975 | High Similarity | NPC471748 |
0.975 | High Similarity | NPC203259 |
0.975 | High Similarity | NPC176740 |
0.975 | High Similarity | NPC190003 |
0.975 | High Similarity | NPC471725 |
0.975 | High Similarity | NPC153755 |
0.975 | High Similarity | NPC175107 |
0.975 | High Similarity | NPC33054 |
0.975 | High Similarity | NPC245452 |
0.975 | High Similarity | NPC155877 |
0.975 | High Similarity | NPC134532 |
0.9748 | High Similarity | NPC52382 |
0.9748 | High Similarity | NPC227508 |
0.9748 | High Similarity | NPC138927 |
0.9748 | High Similarity | NPC270578 |
0.9747 | High Similarity | NPC197285 |
0.9747 | High Similarity | NPC21100 |
0.9745 | High Similarity | NPC222936 |
0.9745 | High Similarity | NPC19709 |
0.9745 | High Similarity | NPC284960 |
0.9689 | High Similarity | NPC101026 |
0.9689 | High Similarity | NPC24043 |
0.9689 | High Similarity | NPC4390 |
0.9689 | High Similarity | NPC21666 |
0.9689 | High Similarity | NPC42773 |
0.9689 | High Similarity | NPC45522 |
0.9689 | High Similarity | NPC169977 |
0.9688 | High Similarity | NPC67105 |
0.9688 | High Similarity | NPC259896 |
0.9688 | High Similarity | NPC235260 |
0.9688 | High Similarity | NPC156869 |
0.9688 | High Similarity | NPC155763 |
0.9688 | High Similarity | NPC20505 |
0.9688 | High Similarity | NPC255157 |
0.9688 | High Similarity | NPC254855 |
0.9688 | High Similarity | NPC136042 |
0.9688 | High Similarity | NPC29958 |
0.9688 | High Similarity | NPC67326 |
0.9686 | High Similarity | NPC92565 |
0.9686 | High Similarity | NPC275454 |
0.9686 | High Similarity | NPC160156 |
0.9684 | High Similarity | NPC311830 |
0.9684 | High Similarity | NPC34531 |
0.9684 | High Similarity | NPC22832 |
0.9682 | High Similarity | NPC189142 |
0.9682 | High Similarity | NPC77660 |
0.963 | High Similarity | NPC294815 |
0.963 | High Similarity | NPC473327 |
0.963 | High Similarity | NPC19108 |
0.963 | High Similarity | NPC220173 |
0.963 | High Similarity | NPC476472 |
0.963 | High Similarity | NPC294629 |
0.963 | High Similarity | NPC16194 |
0.9627 | High Similarity | NPC26230 |
0.9627 | High Similarity | NPC60735 |
0.9627 | High Similarity | NPC476405 |
0.9627 | High Similarity | NPC117260 |
0.9625 | High Similarity | NPC476771 |
0.9623 | High Similarity | NPC210073 |
0.9623 | High Similarity | NPC115674 |
0.9623 | High Similarity | NPC255615 |
0.9623 | High Similarity | NPC67037 |
0.962 | High Similarity | NPC168822 |
0.962 | High Similarity | NPC243930 |
0.962 | High Similarity | NPC270335 |
0.962 | High Similarity | NPC309025 |
0.962 | High Similarity | NPC191306 |
0.962 | High Similarity | NPC88023 |
0.9571 | High Similarity | NPC470949 |
0.9571 | High Similarity | NPC198324 |
0.9571 | High Similarity | NPC202908 |
0.9571 | High Similarity | NPC122467 |
0.9571 | High Similarity | NPC292019 |
0.9571 | High Similarity | NPC65563 |
0.9571 | High Similarity | NPC89127 |
0.9571 | High Similarity | NPC472385 |
0.9571 | High Similarity | NPC14187 |
0.9571 | High Similarity | NPC471669 |
0.9565 | High Similarity | NPC245014 |
0.9565 | High Similarity | NPC285197 |
0.9565 | High Similarity | NPC84265 |
0.9565 | High Similarity | NPC282987 |
0.9563 | High Similarity | NPC149244 |
0.9563 | High Similarity | NPC229729 |
0.9563 | High Similarity | NPC48640 |
0.9557 | High Similarity | NPC300537 |
0.9557 | High Similarity | NPC127782 |
0.9554 | High Similarity | NPC110349 |
0.9512 | High Similarity | NPC258044 |
0.9512 | High Similarity | NPC217520 |
0.9512 | High Similarity | NPC217387 |
0.9512 | High Similarity | NPC196127 |
0.9512 | High Similarity | NPC251417 |
0.9512 | High Similarity | NPC293626 |
0.9512 | High Similarity | NPC267680 |
0.9512 | High Similarity | NPC139571 |
0.9512 | High Similarity | NPC35167 |
0.9512 | High Similarity | NPC168584 |
0.9512 | High Similarity | NPC89052 |
0.9512 | High Similarity | NPC173837 |
0.9509 | High Similarity | NPC49344 |
0.9509 | High Similarity | NPC210094 |
0.9509 | High Similarity | NPC43211 |
0.9509 | High Similarity | NPC34267 |
0.9509 | High Similarity | NPC214621 |
0.9509 | High Similarity | NPC101191 |
0.9509 | High Similarity | NPC264735 |
0.9509 | High Similarity | NPC253685 |
0.9509 | High Similarity | NPC477848 |
0.9509 | High Similarity | NPC115760 |
0.9509 | High Similarity | NPC237435 |
0.9509 | High Similarity | NPC135277 |
0.9509 | High Similarity | NPC223426 |
0.9509 | High Similarity | NPC81042 |
0.9506 | High Similarity | NPC476772 |
0.9503 | High Similarity | NPC45638 |
0.9503 | High Similarity | NPC475942 |
0.9503 | High Similarity | NPC201292 |
0.9503 | High Similarity | NPC58053 |
0.9503 | High Similarity | NPC105025 |
0.9503 | High Similarity | NPC209296 |
0.9503 | High Similarity | NPC186807 |
0.9503 | High Similarity | NPC93337 |
0.9503 | High Similarity | NPC195257 |
0.9503 | High Similarity | NPC226294 |
0.9503 | High Similarity | NPC469931 |
0.95 | High Similarity | NPC254306 |
0.95 | High Similarity | NPC5778 |
0.95 | High Similarity | NPC8856 |
0.95 | High Similarity | NPC236934 |
0.9497 | High Similarity | NPC29830 |
0.9494 | High Similarity | NPC182045 |
0.949 | High Similarity | NPC41121 |
0.949 | High Similarity | NPC472459 |
0.949 | High Similarity | NPC320283 |
0.949 | High Similarity | NPC111929 |
0.9487 | High Similarity | NPC261866 |
0.9455 | High Similarity | NPC470443 |
0.9455 | High Similarity | NPC470444 |
0.9455 | High Similarity | NPC110941 |
0.9455 | High Similarity | NPC241423 |
0.9455 | High Similarity | NPC473571 |
0.9455 | High Similarity | NPC192539 |
0.9455 | High Similarity | NPC473682 |
0.9455 | High Similarity | NPC126784 |
0.9451 | High Similarity | NPC473862 |
0.9451 | High Similarity | NPC144097 |
0.9451 | High Similarity | NPC233994 |
0.9451 | High Similarity | NPC48984 |
0.9451 | High Similarity | NPC211532 |
0.9451 | High Similarity | NPC61904 |
0.9451 | High Similarity | NPC8573 |
0.9451 | High Similarity | NPC219043 |
0.9451 | High Similarity | NPC169733 |
0.9444 | High Similarity | NPC150767 |
0.9444 | High Similarity | NPC224462 |
0.9444 | High Similarity | NPC231194 |
0.9444 | High Similarity | NPC72249 |
0.9444 | High Similarity | NPC78734 |
0.9444 | High Similarity | NPC51326 |
0.9441 | High Similarity | NPC146792 |
0.9441 | High Similarity | NPC477502 |
0.9441 | High Similarity | NPC58716 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC135599 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.975 | High Similarity | NPD6797 | Phase 2 |
0.9689 | High Similarity | NPD7251 | Discontinued |
0.9509 | High Similarity | NPD7808 | Phase 3 |
0.9509 | High Similarity | NPD4338 | Clinical (unspecified phase) |
0.9503 | High Similarity | NPD7054 | Approved |
0.9444 | High Similarity | NPD7472 | Approved |
0.9325 | High Similarity | NPD7074 | Phase 3 |
0.9202 | High Similarity | NPD3818 | Discontinued |
0.9182 | High Similarity | NPD4381 | Clinical (unspecified phase) |
0.9146 | High Similarity | NPD7804 | Clinical (unspecified phase) |
0.908 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.908 | High Similarity | NPD6166 | Phase 2 |
0.908 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.8938 | High Similarity | NPD3817 | Phase 2 |
0.8931 | High Similarity | NPD1934 | Approved |
0.8875 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.879 | High Similarity | NPD1512 | Approved |
0.8765 | High Similarity | NPD3882 | Suspended |
0.8758 | High Similarity | NPD2801 | Approved |
0.8662 | High Similarity | NPD1511 | Approved |
0.865 | High Similarity | NPD4868 | Clinical (unspecified phase) |
0.8598 | High Similarity | NPD7075 | Discontinued |
0.8571 | High Similarity | NPD4380 | Phase 2 |
0.848 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.8476 | Intermediate Similarity | NPD5402 | Approved |
0.8466 | Intermediate Similarity | NPD6801 | Discontinued |
0.843 | Intermediate Similarity | NPD6559 | Discontinued |
0.8415 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8385 | Intermediate Similarity | NPD5403 | Approved |
0.8375 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8313 | Intermediate Similarity | NPD6799 | Approved |
0.8261 | Intermediate Similarity | NPD5401 | Approved |
0.8165 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8165 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8113 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8111 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.811 | Intermediate Similarity | NPD1653 | Approved |
0.8092 | Intermediate Similarity | NPD3751 | Discontinued |
0.807 | Intermediate Similarity | NPD3787 | Discontinued |
0.8059 | Intermediate Similarity | NPD5494 | Approved |
0.8036 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.8012 | Intermediate Similarity | NPD6599 | Discontinued |
0.8012 | Intermediate Similarity | NPD6959 | Discontinued |
0.7987 | Intermediate Similarity | NPD2796 | Approved |
0.7976 | Intermediate Similarity | NPD7819 | Suspended |
0.7976 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7964 | Intermediate Similarity | NPD7411 | Suspended |
0.7943 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7927 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7925 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7919 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.791 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7886 | Intermediate Similarity | NPD7228 | Approved |
0.7861 | Intermediate Similarity | NPD6232 | Discontinued |
0.7831 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7829 | Intermediate Similarity | NPD7473 | Discontinued |
0.7803 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7791 | Intermediate Similarity | NPD6234 | Discontinued |
0.7791 | Intermediate Similarity | NPD919 | Approved |
0.7785 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7785 | Intermediate Similarity | NPD1613 | Approved |
0.7778 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7744 | Intermediate Similarity | NPD6190 | Approved |
0.7735 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7722 | Intermediate Similarity | NPD8313 | Approved |
0.7722 | Intermediate Similarity | NPD8312 | Approved |
0.7716 | Intermediate Similarity | NPD7266 | Discontinued |
0.7713 | Intermediate Similarity | NPD6780 | Approved |
0.7713 | Intermediate Similarity | NPD6781 | Approved |
0.7713 | Intermediate Similarity | NPD6782 | Approved |
0.7713 | Intermediate Similarity | NPD6777 | Approved |
0.7713 | Intermediate Similarity | NPD6776 | Approved |
0.7713 | Intermediate Similarity | NPD6778 | Approved |
0.7713 | Intermediate Similarity | NPD6779 | Approved |
0.7706 | Intermediate Similarity | NPD37 | Approved |
0.7701 | Intermediate Similarity | NPD1247 | Approved |
0.7684 | Intermediate Similarity | NPD7435 | Discontinued |
0.7683 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7674 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7674 | Intermediate Similarity | NPD4966 | Approved |
0.7674 | Intermediate Similarity | NPD4965 | Approved |
0.7673 | Intermediate Similarity | NPD1240 | Approved |
0.767 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7656 | Intermediate Similarity | NPD7584 | Approved |
0.7625 | Intermediate Similarity | NPD230 | Phase 1 |
0.7614 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7609 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.758 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7578 | Intermediate Similarity | NPD1607 | Approved |
0.7577 | Intermediate Similarity | NPD8151 | Discontinued |
0.7576 | Intermediate Similarity | NPD3750 | Approved |
0.7562 | Intermediate Similarity | NPD943 | Approved |
0.7553 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7545 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7532 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD1933 | Approved |
0.75 | Intermediate Similarity | NPD7696 | Phase 3 |
0.75 | Intermediate Similarity | NPD7697 | Approved |
0.75 | Intermediate Similarity | NPD7698 | Approved |
0.7484 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7471 | Intermediate Similarity | NPD7768 | Phase 2 |
0.747 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7461 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7461 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7457 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7449 | Intermediate Similarity | NPD7874 | Approved |
0.7449 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7447 | Intermediate Similarity | NPD6534 | Approved |
0.7447 | Intermediate Similarity | NPD6535 | Approved |
0.7439 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7438 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7436 | Intermediate Similarity | NPD7701 | Phase 2 |
0.7429 | Intermediate Similarity | NPD3749 | Approved |
0.7418 | Intermediate Similarity | NPD7240 | Approved |
0.7396 | Intermediate Similarity | NPD2533 | Approved |
0.7396 | Intermediate Similarity | NPD2532 | Approved |
0.7396 | Intermediate Similarity | NPD2534 | Approved |
0.7378 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD2935 | Discontinued |
0.733 | Intermediate Similarity | NPD7699 | Phase 2 |
0.733 | Intermediate Similarity | NPD7700 | Phase 2 |
0.7323 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7323 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7323 | Intermediate Similarity | NPD7801 | Approved |
0.7305 | Intermediate Similarity | NPD2800 | Approved |
0.7305 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7301 | Intermediate Similarity | NPD447 | Suspended |
0.7282 | Intermediate Similarity | NPD8319 | Approved |
0.7282 | Intermediate Similarity | NPD8320 | Phase 1 |
0.7278 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD3748 | Approved |
0.7268 | Intermediate Similarity | NPD6823 | Phase 2 |
0.7259 | Intermediate Similarity | NPD7585 | Approved |
0.7229 | Intermediate Similarity | NPD6099 | Approved |
0.7229 | Intermediate Similarity | NPD6100 | Approved |
0.7222 | Intermediate Similarity | NPD6798 | Discontinued |
0.7219 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7219 | Intermediate Similarity | NPD8150 | Discontinued |
0.7209 | Intermediate Similarity | NPD920 | Approved |
0.7208 | Intermediate Similarity | NPD7583 | Approved |
0.7202 | Intermediate Similarity | NPD6674 | Discontinued |
0.7202 | Intermediate Similarity | NPD1243 | Approved |
0.7197 | Intermediate Similarity | NPD1091 | Approved |
0.7193 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7189 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7178 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7174 | Intermediate Similarity | NPD5953 | Discontinued |
0.7173 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7173 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7169 | Intermediate Similarity | NPD7033 | Discontinued |
0.7165 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD6651 | Approved |
0.7135 | Intermediate Similarity | NPD7390 | Discontinued |
0.7126 | Intermediate Similarity | NPD3226 | Approved |
0.7126 | Intermediate Similarity | NPD7458 | Discontinued |
0.7113 | Intermediate Similarity | NPD7237 | Clinical (unspecified phase) |
0.7102 | Intermediate Similarity | NPD6844 | Discontinued |
0.7101 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7099 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7099 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7093 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7091 | Intermediate Similarity | NPD6355 | Discontinued |
0.7087 | Intermediate Similarity | NPD8155 | Clinical (unspecified phase) |
0.7081 | Intermediate Similarity | NPD2798 | Approved |
0.7076 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7065 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7059 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7037 | Intermediate Similarity | NPD9494 | Approved |
0.7031 | Intermediate Similarity | NPD6214 | Clinical (unspecified phase) |
0.7031 | Intermediate Similarity | NPD6212 | Phase 3 |
0.7031 | Intermediate Similarity | NPD6213 | Phase 3 |
0.7022 | Intermediate Similarity | NPD5353 | Approved |
0.7019 | Intermediate Similarity | NPD5619 | Clinical (unspecified phase) |
0.7019 | Intermediate Similarity | NPD1203 | Approved |
0.7012 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7012 | Intermediate Similarity | NPD2313 | Discontinued |
0.7 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.6995 | Remote Similarity | NPD2403 | Approved |
0.6994 | Remote Similarity | NPD7422 | Clinical (unspecified phase) |
0.6988 | Remote Similarity | NPD5123 | Clinical (unspecified phase) |
0.6988 | Remote Similarity | NPD5124 | Phase 1 |
0.6988 | Remote Similarity | NPD1899 | Clinical (unspecified phase) |
0.6982 | Remote Similarity | NPD2346 | Discontinued |
0.6982 | Remote Similarity | NPD2344 | Approved |
0.6981 | Remote Similarity | NPD1547 | Clinical (unspecified phase) |
0.6978 | Remote Similarity | NPD5710 | Approved |
0.6978 | Remote Similarity | NPD5711 | Approved |
0.697 | Remote Similarity | NPD7680 | Approved |
0.6964 | Remote Similarity | NPD1509 | Clinical (unspecified phase) |
0.6964 | Remote Similarity | NPD2799 | Discontinued |
0.6943 | Remote Similarity | NPD1548 | Phase 1 |
0.6937 | Remote Similarity | NPD9269 | Phase 2 |
0.6932 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.6928 | Remote Similarity | NPD4060 | Phase 1 |
0.6919 | Remote Similarity | NPD2163 | Approved |
0.6911 | Remote Similarity | NPD6841 | Approved |
0.6911 | Remote Similarity | NPD6842 | Approved |
0.6911 | Remote Similarity | NPD6843 | Phase 3 |
0.6909 | Remote Similarity | NPD3268 | Approved |
0.69 | Remote Similarity | NPD7211 | Clinical (unspecified phase) |
PubChem CID   | 40491193 |
ChEMBL   | CHEMBL454576 |
ZINC   |
Molecular Weight:   | 464.10 |
ALogP:   | -4.8524 |
MLogP:   | 2.45 |
XLogP:   | -0.185 |
# Rotatable Bonds:   | 12 |
Polar Surface Area:   | 206.6 |
# H-Bond Aceptor:   | 6 |
# H-Bond Donor:   | 8 |
# Rings:   | 4 |
# Heavy Atoms:   | 33 |